【レポートの概要（一部）】
TABLE OF CONTENTS
1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.2 MARKET SIZE ESTIMATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.4 MARKET SHARE ESTIMATION 29
2.5 KEY DATA FROM SECONDARY SOURCES 29
2.6 KEY DATA FROM PRIMARY SOURCES 30
2.7 KEY INDUSTRY INSIGHTS 31
2.8 ASSUMPTIONS FOR THE STUDY 31
3 EXECUTIVE SUMMARY 32
4 PREMIUM INSIGHTS 37
4.1 HIGH GROWTH POTENTIAL OF THE COAGULATION ANALYZERS MARKET 37
4.2 GLOBAL CLINICAL LABORATORY ANALYZERS, BY TYPE 38
4.3 GLOBAL COAGULATION ANALYZERS MARKET, BY REGION 39
4.4 COAGULATION ANALYZERS MARKET, BY INSTRUMENT 40
4.5 COAGULATION ANALYZERS MARKET, BY TEST 41
4.6 GLOBAL COAGULATION ANALYZERS MARKET, BY END USER 42
4.7 LIFECYCLE ANALYSIS, BY REGION 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 45
5.2 MARKET SEGMENTATION 45
5.2.1 BY PRODUCT 45
5.2.2 BY TEST 46
5.2.3 BY TECHNOLOGY 46
5.2.4 BY END USER 47
5.2.5 BY REGION 48
5.3 MARKET DYNAMICS 49
5.4 DRIVERS 50
5.4.1 INCREASING PREVALENCE OF DISEASES AND RISING NUMBER OF SURGICAL PROCEDURES 50
5.4.2 INCREASING ADOPTION OF AUTOMATED COAGULATION INSTRUMENTS BY DIAGNOSTIC LABORATORIES 50
5.4.3 DEVELOPMENT OF HIGH-SENSITIVITY POINT-OF-CARE (POC) COAGULATION TESTING 50
5.4.4 GROWTH IN AGING POPULATION 50
5.4.5 TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES 51
5.5 RESTRAINTS 53
5.5.1 SLOW ADOPTION OF ADVANCED COAGULATION INSTRUMENTS IN EMERGING ECONOMIES 53
5.5.2 HIGH COST OF FULLY AUTOMATED COAGULATION ANALYZERS 53
5.6 OPPORTUNITIES 54
5.6.1 RAPID GROWTH IN THE COAGULATION MARKET IN EMERGING ECONOMIES 54
5.6.2 INCREASING NUMBER OF HEMOPHILIC PATIENTS 54
5.7 CHALLENGE 55
5.7.1 STRINGENT AND TIME-CONSUMING REGULATORY POLICIES 55
6 INDUSTRY INSIGHTS 56
6.1 INTRODUCTION 56
6.2 PORTER’S FIVE FORCES ANALYSIS 56
6.2.1 THREAT OF NEW ENTRANTS 57
6.2.2 THREAT OF SUBSTITUTES 57
6.2.3 BARGAINING POWER OF SUPPLIERS 57
6.2.4 BARGAINING POWER OF BUYERS 58
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 58
6.3 SUPPLY CHAIN ANALYSIS 59
6.3.1 KEY INFLUENCERS 60
6.4 STRATEGIC BENCHMARKING 61
7 HEMOSTASIS/COAGULATION ANALYZERS MARKET, BY TYPE OF TEST 62
7.1 INTRODUCTION 63
7.2 PROTHROMBIN TIME (PT/INR) TEST 64
7.3 ACTIVATED CLOTTING TIME (ACT/APTT) TEST 67
7.4 D-DIMER TEST 69
7.5 FIBRINOGEN TEST 71
7.6 OTHERS COAGULATION TEST 73
8 COAGULATION ANALYZERS MARKET, BY PRODUCT TYPE 76
8.1 INTRODUCTION 77
8.2 CLINICAL LABORATORY COAGULATION ANALYZERS 78
8.2.1 INSTRUMENTS 81
8.2.1.1 Fully Automated Coagulation Analyzers 85
8.2.1.2 Semi-automated and Manual Coagulation Analyzers 87
8.2.2 COAGULATION CONSUMABLES 90
8.2.2.1 Reagents 92
8.2.2.2 Standards, Controls, and Calibrators 94
8.3 POINT-OF-CARE TESTING COAGULATION ANALYZERS 97
9 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY 100
9.1 INTRODUCTION 101
9.2 PHOTO OPTICAL TECHNOLOGY 101
9.3 MECHANICAL TECHNOLOGY 102
9.4 ELECTROCHEMICAL TECHNOLOGY 102
9.5 OTHER TECHNOLOGIES 102
10 HEMOSTASIS/COAGULATION ANALYZERS MARKET, BY END USER 103
10.1 INTRODUCTION 104
10.2 RESEARCH INSTITUTES 105
10.3 DIAGNOSTIC LABORATORIES 108
10.4 STANDALONE HOSPITALS 110
10.5 OTHER END USERS 113
11 COAGULATION ANALYZERS MARKET, BY REGION 116
11.1 INTRODUCTION 117
11.2 NORTH AMERICA 121
11.2.1 U.S. 126
11.2.2 CANADA 129
11.3 EUROPE 133
11.3.1 GERMANY 136
11.3.2 FRANCE 139
11.3.3 U.K. 142
11.3.4 ITALY 145
11.3.5 SPAIN 148
11.3.6 REST OF EUROPE (ROE) 151
11.4 ASIA-PACIFIC 153
11.4.1 JAPAN 157
11.4.2 CHINA 160
11.4.3 INDIA 164
11.4.4 REST OF ASIA-PACIFIC (ROAPAC) 168
11.5 REST OF THE WORLD (ROW) 171
12 COMPETITIVE LANDSCAPE 175
12.1 OVERVIEW 175
12.2 MARKET SHARE ANALYSIS 176
12.2.1 MARKET SHARE ANALYSIS FOR CLINICAL LABORATORY ANALYZERS MARKET 176
12.2.2 MARKET SHARE ANALYSIS FOR POINT-OF-CARE COAGULATION ANALYZERS MARKET 177
12.3 COMPETITIVE SITUATION AND TRENDS 178
12.3.1 EXPANSIONS 179
12.3.2 NEW PRODUCT LAUNCHES 180
12.3.3 AGREEMENTS, PARTNERSHIPS, & ALLIANCES 181
12.3.4 ACQUISITIONS 182
12.3.5 OTHER DEVELOPMENTS 182
13 COMPANY PROFILES 183
13.1 INTRODUCTION 183
13.2 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG) 184
13.2.1 BUSINESS OVERVIEW 184
13.2.2 SIEMENS AG: COMPANY SNAPSHOT 184
13.2.3 PRODUCT PORTFOLIO 185
13.2.4 KEY STRATEGIES 186
13.2.5 RECENT DEVELOPMENTS 186
13.3 SYSMEX CORPORATION 188
13.3.1 BUSINESS OVERVIEW 188
13.3.2 SYSMEX CORPORATION: COMPANY SNAPSHOT 188
13.3.3 PRODUCT PORTFOLIO 189
13.3.4 KEY STRATEGIES 190
13.3.5 RECENT DEVELOPMENTS 190
13.4 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.) 191
13.4.1 BUSINESS OVERVIEW 191
13.4.2 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 191
13.4.3 PRODUCT PORTFOLIO 192
13.4.4 KEY STRATEGY 192
13.4.5 RECENT DEVELOPMENTS 192
13.5 NIHON KOHDEN CORPORATION 193
13.5.1 BUSINESS OVERVIEW 193
13.5.2 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 193
13.5.3 PRODUCT PORTFOLIO 194
13.5.4 KEY STRATEGY 194
13.5.5 RECENT DEVELOPMENTS 194
13.6 INTERNATIONAL TECHNIDYNE CORPORATION (ITC) 195
13.6.1 BUSINESS OVERVIEW 195
13.6.2 KEY FINANCIALS 195
13.6.3 PRODUCTS 195
13.6.4 KEY STRATEGY 195
13.6.5 RECENT DEVELOPMENTS 195
13.7 HELENA LABORATORIES 196
13.7.1 BUSINESS OVERVIEW 196
13.7.2 KEY FINANCIALS 196
13.7.3 PRODUCT PORTFOLIO 196
13.8 ALERE, INC. 197
13.8.1 BUSINESS OVERVIEW 197
13.8.2 ALERE, INC.: COMPANY SNAPSHOT 197
13.8.3 PRODUCT PORTFOLIO 198
13.8.4 KEY STRATEGY 198
13.9 DIAGNOSTICA STAGO SAS 199
13.9.1 BUSINESS OVERVIEW 199
13.9.2 KEY FINANCIALS 199
13.9.3 PRODUCT PORTFOLIO 199
13.9.4 KEY STRATEGY 199
13.9.5 RECENT DEVELOPMENTS 200
13.10 INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP) 201
13.10.1 BUSINESS OVERVIEW 201
13.10.2 KEY FINANCIALS 201
13.10.3 PRODUCT PORTFOLIO 201
13.10.4 KEY STRATEGY 202
13.10.5 RECENT DEVELOPMENTS 202
13.11 THERMO FISHER SCIENTIFIC, INC. 203
13.11.1 BUSINESS OVERVIEW 203
13.11.2 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 203
13.11.3 PRODUCT PORTFOLIO 204
13.11.4 KEY STRATEGIES 204
13.11.5 RECENT DEVELOPMENTS 204
14 APPENDIX 205
14.1 INSIGHTS FROM INDUSTRY EXPERTS 205
14.2 DISCUSSION GUIDE 206
14.3 COMPANY DEVELOPMENTS (2012–2014) 209
14.3.1 SYSMEX CORPORATION 209
14.3.2 NIHON KOHEDEN CORPORATION 209
14.3.3 SIEMENS HEALTHCARE 210
14.3.4 DIAGNOSTICA STAGO, INC. 210
14.3.5 INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP) 210
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 211
14.5 AVAILABLE CUSTOMIZATIONS 211
14.6 RELATED REPORTS 212
【レポート販売概要】
■ タイトル：血液凝固分析装置の世界市場■ 英文：Coagulation/Hemostasis Analyzer Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019
■ 発行日：2015年3月20日
■ 調査会社：MarketsandMarkets
■ 商品コード：MAM-MD-3255
■ 調査対象地域：グローバル
- 抗凝固療法の米国市場予測（～2022年）“The US anticoagulation therapy market projected to grow at a CAGR of 8.5%.”The US anticoagulation therapy market is projected to reach USD 27.83 billion by 2022 from an estimated USD 18.49 billion in 2017, at a CAGR of 8.5%. The US anticoagulation therapy market is segmented into products (anticoagulation drugs, PT/INR testing devices) and anticoagulation clinics. The growth of the anticoagulatio …
- 軽自動車の北米市場予測（～2021）The light duty vehicle market for North America is projected to grow at a CAGR of 5.65% during the forecast period, to reach 24540.0 thousand units by 2021, from an estimated 18647.1 thousand units in 2016. The base year for the report is 2015 and the forecast year is 2021. The increasing demand for light duty vehicles in North America, stringent emission regulations leading to light weighting/eng …
- 世界の集光型太陽熱発電市場The global concentrated solar power market has great potential for growth and expansion in the coming years. Companies that have been successful in operating CSP prototype systems in global pilot locations are progressing towards multi-megawatt CSP projects. These companies are targeting high DNI regions to install CSP systems at high efficiencies. The global CSP industry is booming at this time a …
- アフェレーシスの世界市場予測（～2021年）：血漿分離器、血漿成分分離器、血液灌流、消耗品The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence of chronic diseases and growing number of complex surgeries. Similarly, the increasing number of organ transplant procedures also supports the growth of the market. In this report, the market is se …
- Talisman Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Talisman Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Talisman Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- CaaS（サービスとしてのコンテナ）の世界市場予測（～2022年）The increasing need to improve the end-users’ Quality of Experience (QoE) is driving the CaaS market growth. The Containers as a Service (CaaS) market is expected to grow from USD 930.4 million in 2017 to USD 4,080.4 million by 2022, at a Compound Annual Growth Rate (CAGR) of 34.4%. The market is driven by various factors, such as the benefits of operational simplicity, platform independency, reso …
- グローバル商用業航空宇宙市場におけるトップ10企業分析Synopsis The Strategic Defence Intelligence Global Top 10 Commercial Aerospace Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global commercial aerospace industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated. General Elec …
- 抗肥満薬の世界市場：末梢作用型抗肥満薬、中枢作用型抗肥満薬About Obesity Obesity is a medical condition in which there is surplus accumulation of fat in the body. It is linked with increased illness risk, disability, and death. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure. TechNavio's analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 39.45 percent o …
- 水溶性塗料の世界市場：水溶性ペンキ、エマルジョン・ラテックス塗料、アルキド塗料About Waterborne Coatings Waterborne coating is a type of coating, which uses water as a solvent. Water is used as a dispersal agent for resins, thereby making them eco-friendly and easy to use. Water constitutes 80% of the volume of the paint, with traces of other solvents, such as glycol ethers. These coatings are gaining wide application in the US and Western Europe because of their low level o …
- サウジアラビアの土工機械市場2016-2020About Earth Moving Equipment Market in Saudi Arabia Earthmoving equipment generally refers to heavy equipment that are extensively used in the construction industry to move large quantities of earth, dig foundations, and landscape areas. Excavators, loaders, and construction tractors are the different types of earthmoving equipment. The market for earthmoving equipment in Saudi Arabia is one of th …
- 世界のIT資産管理ソフト市場動向（2012-2016）TechNavio’s analysts forecast the Global IT Asset Management Software market to grow at a CAGR of 9.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased need for ITAM cost reduction. The Global IT Asset Management Software market has also been witnessing the emergence of cloud computing. However, the high deployment cost could pose a chall …
- イオン交換樹脂の世界市場2015-2019About ion exchange resins Ion exchange resins belong to a category of polymers that have the ability to replace ions present in solutions with their own. This ability is commonly exhibited by naturally occurring substances such as proteins, celluloses, soil particles, and live cells. However, this exchange of ions does not alter the physical structure of the material. Ion exchangers belong to a cl …
- CNV-2197944（神経因性疼痛）：医薬品市場予測及び分析（～2022）CNV-2197944 (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Althoug …
- 世界のイベント管理ソフトウェア市場：カンファレンス、博覧会、展示会管理About Event Management Software Event management software refers to a wide range of software products used in the management of professional and academic conferences, trade exhibitions and events such as continuing professional development meetings. Event management software applications include online registration, online payment, venue selection, procurement, sourcing, paper management, exhibiti …
- 世界の内分泌機能検査市場Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 327-page report from VPGMarketResearch.com contains 75 tables and provides analysis of the global endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The repor …
